Several GLP-1 medications are available, including: Mounjaro (tirzepatide) Ozempic (semaglutide) Rybelsus (oral semaglutide) Wegovy (semaglutide) Zepbound (tirzepatide) Ozempic, Rybelsus, and Wegovy are traditional GLP-1 agonists, which means they primarily activate GLP-1 receptors
Liraglutide also has an FDA-approved obesity indication (Saxenda, 8.0% weight loss in SCALE), proven cardiovascular benefit (LEADER, 13% MACE reduction), and once-daily dosing without microsphere-related injection site reactions
Dual-Agonist Comparisons Tirzepatide (found in medications like Mounjaro) targets two receptors: GLP-1 and GIP
At Blue Haven Rx, our goal is to provide the clear, honest information you need to decide whats best for your long-term health
Arginine is often evaluated in laboratory settings for its relationship to nitric-oxidelinked and amino-acid pathway biology